Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neoplastic Cells, Circulating 1Neoplasms, Germ Cell and Embryonal 1Neoplasm, Residual 1Carcinoma, Merkel Cell 1Breast Neoplasms 1

Interventions

blinatumomab 2venetoclax 1osimertinib 1Vincristine 1Transplantation 1Sorafenib 1Radiotherapy 1Oxaliplatin 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methotrexate 1Maintenance 1Liquid Biopsy 1Leucovorin 1Irinotecan 1Hematologic Tests 1Fluorouracil 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Blood Specimen Collection 1BEBT-908 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasm, Residual × Hematologic Tests × Clear all
NCT07514715 2026-04-13

RT4

The Lymphoma Academic Research Organisation

Not yet recruiting
129 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡